Back to News
Market Impact: 0.2

Cresud reports exercise of warrants and increase in share capital

CRESY
Derivatives & VolatilityFutures & OptionsCompany Fundamentals
Cresud reports exercise of warrants and increase in share capital

Cresud Inc. (NASDAQ:CRES) announced that warrant holders exercised rights between September 17-25, leading to the issuance of 17,769,882 ordinary shares and generating $7,141,716 in capital. This transaction increased the company's outstanding shares from 614,074,273 to 631,844,155 and reduced outstanding warrants from 73,294,802 to 60,669,566. The exercise provides capital to Cresud while diluting existing shareholders, with a fully diluted share count now projected at 717,236,569 should all remaining warrants be exercised.

Analysis

Cresud Inc. has secured $7.14 million in fresh capital through the exercise of warrants, leading to the issuance of 17,769,882 new ordinary shares. This transaction increases the company's total outstanding shares by approximately 2.9%, from 614.1 million to 631.8 million, resulting in immediate dilution for existing shareholders. The exercise, conducted at a price of $0.4019 per share, reduces the number of outstanding warrants to 60.7 million. A significant warrant overhang remains, with the potential for an additional 85.4 million shares to be issued in the future. Should all remaining warrants be exercised, Cresud's fully diluted share count would reach 717.2 million, representing a substantial potential dilution from the pre-exercise base. This event highlights a trade-off for the company: a beneficial cash infusion for operations or investment versus a notable increase in the share base that will impact per-share metrics.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

CRESY0.10

Key Decisions for Investors

  • Investors should update their valuation models to reflect the new outstanding share count of 631.8 million and assess the impact on earnings per share.
  • Monitor the potential for future dilution, as the 60.7 million outstanding warrants could increase the share count by a further 13.5% if fully exercised.
  • Consider the warrant exercise price of $0.4019 as a reference point; continued trading of CRESY's stock well above this level will incentivize further exercises and accelerate dilution.